相关实验视频
Updated: May 30, 2025

14:57
Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
9.5K
人环素分解并恢复突变的p63功能:AEC综合征的潜在治疗方法
Fabiana Boncimino1, Ludovica D'Auria2,3, Kristina Todorova1
1Cutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, 02129, USA.
Cell death discovery
|January 25, 2025
概括
研究人员确定了多克索鲁比和埃皮鲁比作为基洛布莱法龙-外皮缺陷-左唇/部 (AEC) 综合征的潜在治疗方法. 这些药物减少有害的蛋白质聚合,为AEC患者的慢性皮肤侵蚀提供了希望.
科学领域:
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
- 皮肤病学 皮肤病学
背景情况:
- 安基洛布莱法龙-外皮缺陷-左唇/部 (AEC) 综合征是一种罕见的遗传疾病,由TP63基因突变引起.
- 突变导致p63蛋白错误折叠,聚合和主导负效应,导致慢性皮肤侵蚀.
- 目前用于AEC综合征皮肤侵蚀的治疗方法是无效的.
研究的目的:
- 确定可以减轻p63蛋白聚合并恢复其功能的化合物.
- 评估已识别的化合物对AEC综合征的治疗潜力.
- 研究AEC综合征中慢性皮肤侵蚀的治疗方法.
主要方法:
- 使用野生类型和突变p63共传染模型对表观遗传和FDA批准的化合物的高通量查.
- 从有条件的ΔNp63αL514FAEC小鼠模型中测试初级角质细胞中的有效化合物.
- 评估化合物在减少蛋白质聚合和恢复p63标基因表达方面的疗效.
主要成果:
- 发现多克索鲁比和埃皮鲁比可以减轻p63蛋白质的聚合,并恢复其交换活化功能.
- 使用这些化合物的治疗减少了蛋白质聚合,并在AEC小鼠模型中恢复了状细胞特异的p63向基因表达.
- 一种毒性较低的类似物,二Me-Doxorubicin,也促进了突变的p63分解,并挽救了转录活性.
结论:
- doxorubicin,Epirubicin 和 diMe-Doxorubicin 通过解决突变 p63 聚合,显示出治疗 AEC 综合征的潜力.
- 这些化合物增加了p63的单体异型,并重新激活了其转录功能.
- 这些发现表明,与AEC综合征相关的慢性皮肤侵蚀存在潜在的治疗策略.
相关概念视频
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
DNA Damage can Stall the Cell Cycle
9.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K
Separation of Sister Chromatids
3.6K
At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...
At the onset of anaphase, separase, a proteolytic enzyme, is...
3.6K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K

